Nello Mainolfi, CEO of Kymera Therapeutics KYMR, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $18.2M. The latest trade was on 04/29.

NM

NM

Nello Mainolfi

CEO

Company

Kymera Therapeutics KYMR

First filing

23/03/03

Trades

52 trades

Buys / sales

0 / 16

12-month net buying

−$18.2M

Last trade

04/29

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	04/29	04/29	30,000 sh3 trades	$81.18avg.	$2,435,377.2	−4.3%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	02/25	02/25	30,000 sh5 trades	$90.26avg.	$2,707,812.59	−4.3%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	25/12/31	25/12/31	30,000 sh2 trades	$78.06avg.	$2,341,927.98	−4.3%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	25/12/08	25/12/08	100,000 sh	$89.17	$8,917,000	−13.1%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	25/10/29	25/10/29	30,000 sh3 trades	$60.99avg.	$1,829,775.28	−4.3%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	25/09/16	25/09/16	30,000 sh	$49.00	$1,470,000	−4.3%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	25/06/03	25/06/03	30,000 sh	$49.00	$1,470,000	−4.3%